This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) and oral semaglutide (Rybelsus®). Injections are usually more ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

A new animal study raises important questions about a little-known ingredient used in oral weight-loss medications. A pill can feel simpler than a shot, but it also changes what else your body is ...

Semaglutide, the popular weight loss and diabetes drug, now has the green light to treat moderate to severe metabolic dysfunction-associated steatohepatitis (MASH). If you have the condition and are ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

In A Nutshell A new animal study found that SNAC, the absorption-boosting additive in Rybelsus (oral semaglutide), was linked to significant reductions in gut bacteria associated with fiber ...

Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular benefits for selected patients without diabetes who have established heart ...

Semaglutide shows promise in improving liver health and metabolic outcomes in MASH, enhancing steatohepatitis resolution and cardiometabolic measures. A large meta-analysis, published in Diabetology & ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...

Please provide your email address to receive an email when new articles are posted on . In patients with type 2 diabetes, CagriSema lowered HbA1c to a greater degree than semaglutide at 68 weeks.